Bulletin
Investor Alert

New York Markets Open in:

Karuna Therapeutics Inc.

NAS: KRTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/212846564/composite

$

222.00

Change

-1.63 -0.73%

Volume

Volume 3,392

Nov 28, 2022, 4:09 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/212846564/composite

Previous close

$ 230.95

$ 223.63

Change

-7.32 -3.17%

Day low

Day high

$223.18

$232.20

Open
Open: 230.95

52 week low

52 week high

$92.26

$278.25

Open

Market cap

$7.94B

Average volume

330,616

P/E ratio

N/A

Rev. per Employee

$358,669

EPS

-7.45

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/krtx

MarketWatch News on KRTX

  1. Karuna Therapeutics stock price target raised to $295 from $260 at Stifel Nicolaus

    5:33 a.m. Sept. 13, 2022

    - Tomi Kilgore

  2. 10 Stocks Driving the Biotech Resurgence

    7:49 a.m. Aug. 18, 2022

    - Barron's Online

  3. Karuna Therapeutics stock price target raised to $300 from $150 at Maxim Group

    6:59 a.m. Aug. 9, 2022

    - Tomi Kilgore

  4. Karuna Therapeutics stock price target raised to $276 from $190 at Mizuho

    6:43 a.m. Aug. 9, 2022

    - Tomi Kilgore

  5. Karuna Therapeutics stock price target raised to $276 from $190 at Mizuho

    5:20 a.m. Aug. 9, 2022

    - Tomi Kilgore

  6. Karuna's Schizophrenia Data Are 'Best Case Scenario' for the Stock

    12:58 p.m. Aug. 8, 2022

    - Barron's Online

  7. Biotech Stocks Finally Rose in June. What Does It Mean?

    8:07 a.m. July 1, 2022

    - Barron's Online

  8. Seven reasons the beleaguered biotech sector is now a ‘buy’

    7:43 a.m. June 21, 2022

    - Michael Brush

  9. Karuna Therapeutics initiated at overweight with $162 price target at JPMorgan

    6:26 a.m. Sept. 30, 2021

    - Tonya Garcia

  10. Cerevel Test Data Scrambles Schizophrenia Stocks

    7:19 a.m. June 30, 2021

    - Barron's Online

  11. Karuna Therapeutics stock price target raised to $150 from $116 at Mizuho

    5:59 a.m. Feb. 26, 2021

    - Tomi Kilgore

  12. The Case for AbbVie as a Top Biopharma Stock in 2021

    8:45 a.m. Jan. 7, 2021

    - Barron's Online

  13. Karuna Therapeutics stock price target raised to $126 from $117 at Wedbush

    6:05 a.m. June 2, 2020

    - Tomi Kilgore

  14. Karuna Therapeutics started at outperform with $125 stock price target at Oppenheimer

    6:40 a.m. April 28, 2020

    - Tomi Kilgore

  15. Loading more headlines...
/news/nonmarketwatch/company/us/krtx

Other News on KRTX

  1. Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

    6:20 a.m. Nov. 23, 2022

    - Zacks.com

  2. GENERAL ATLANTIC, L.P. Buys 3, Sells 2 in 3rd Quarter

    2:00 p.m. Nov. 15, 2022

    - GuruFocus.com

  3. GREAT POINT PARTNERS LLC Buys 2, Sells 3 in 3rd Quarter

    10:00 a.m. Nov. 15, 2022

    - GuruFocus.com

  4. HAMILTON LANE ADVISORS LLC Buys 3, Sells 2 in 3rd Quarter

    10:00 a.m. Nov. 9, 2022

    - GuruFocus.com

  5. Should You Invest in the SPDR S&P Biotech ETF (XBI)?

    6:20 a.m. Nov. 7, 2022

    - Zacks.com

  6. Karuna Therapeutics GAAP EPS of -$2.38 misses by $0.27

    9:16 a.m. Nov. 3, 2022

    - Seeking Alpha

  7. 10-Q: KARUNA THERAPEUTICS, INC.

    6:49 a.m. Nov. 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. Deal Activity Could Jumpstart Biotechnology

    11:35 p.m. Oct. 31, 2022

    - Seeking Alpha

  9. Miller Opportunity Equity 3Q22 Quarterly Investment Review

    9:45 p.m. Oct. 26, 2022

    - Seeking Alpha

  10. Clarius Group, LLC Buys 3, Sells 2 in 3rd Quarter

    5:00 p.m. Oct. 24, 2022

    - GuruFocus.com

  11. Biotech Stocks Well-Positioned For Fourth Quarter

    8:30 a.m. Oct. 11, 2022

    - Seeking Alpha

  12. Karuna Therapeutics falls as CFO sells over $3M shares

    1:35 p.m. Oct. 5, 2022

    - Seeking Alpha

  13. Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

    6:20 a.m. Sept. 23, 2022

    - Zacks.com

  14. Loading more headlines...
/news/pressrelease/company/us/krtx

Press Releases on KRTX

  1. Karuna Therapeutics to Present at Upcoming Investor Conferences

    5:30 a.m. Sept. 1, 2022

    - BusinessWire - BZX

  2. PureTech Health plc – Half-Year Report

    1:07 a.m. Aug. 25, 2022

    - BusinessWire - BZX

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.